Iloperidone LAI is under clinical development by Vanda Pharmaceuticals and currently in Phase II for Schizophrenia.

Evenamide is under clinical development by Newron Pharmaceuticals and currently in Phase III for Schizophrenia.

A new study hints at a "previously recognized" mechanism that links a rare chromosomal disorder to schizophrenia.

Through Dec. 20, the FDA approved 50 brand new medicines, defined as proteins, small molecules, or other chemicals this year.

It might be hard to learn about a person's mental illness just by looking at their face, but a new study seemingly points to ...

A classroom-style treatment teaches patients with schizophrenia, bipolar disorder and other illnesses to carry on their lives ...

The state of Indiana intends to carry out its first execution in 15 years before sunrise Wednesday, though attorneys for the ...

Schizophrenia, a complex mental health condition that affects how a person thinks, feels, and behaves, requires a ...

Intermittent theta burst stimulation over the left dorsolateral prefrontal cortex was associated with improved schizophrenia symptoms.

From a pig kidney transplant to restoring genetic deafness, 2024 was a year full of medical breakthroughs. The breakthroughs include the discovery of a cause of an autoimmune disease, the development ...

Brain and neuronal changes can be affected by cerebrospinal fluid (CSF) crossing the blood-brain barrier. In a recent review, ...